NCCN Task Force

Clinical utility of PET in a variety of tumor types

Donald A. Podoloff, Douglas W. Ball, Edgar Ben-Josef, Al B. Benson, Steven J. Cohen, R. Edward Coleman, Dominique Delbeke, Maria Ho, David H. Ilson, Gregory P. Kalemkerian, Richard J. Lee, Jay S. Loeffler, Homer A. Macapinlac, Robert J. Morgan, Barry Alan Siegel, Seema Singhal, Douglas Tyler, Richard J. Wong

Research output: Contribution to journalArticle

83 Citations (Scopus)

Abstract

Use of PET is widespread and increasing in the United States, mainly for oncologic applications. In November 2006, the National Comprehensive Cancer Network (NCCN) gathered a panel of experts to review the literature and develop clinical recommendations for using PET scans in lymphoma and non-small cell lung, breast, and colorectal cancers. However, because its use is not restricted to these diseases, and evidence is accumulating for its application in other types of cancers, NCCN convened a second meeting in December 2008 to expand on the initial report. A multidisciplinary panel met to discuss the current data on PET application for various tumor types, including genitourinary, gynecologic, pancreatic, hepatobiliary, thyroid, brain, small cell lung, gastric, and esophageal cancers, and sarcoma and myeloma. This report summarizes the proceedings of this meeting, including discussions of the background of PET, the role of PET in oncology, principles of PET use, emerging applications, and possible future developments.

Original languageEnglish (US)
JournalJNCCN Journal of the National Comprehensive Cancer Network
Volume7
Issue numberSUPPL. 2
StatePublished - 2009
Externally publishedYes

Fingerprint

Advisory Committees
Neoplasms
Small Cell Lung Carcinoma
Esophageal Neoplasms
Non-Small Cell Lung Carcinoma
Sarcoma
Positron-Emission Tomography
Stomach Neoplasms
Colorectal Neoplasms
Lymphoma
Thyroid Gland
Breast Neoplasms
Brain

Keywords

  • Biliary tract cancer
  • Brain cancer
  • Esophageal cancer
  • Gastric cancer
  • Genitourinary cancers
  • Gynecological cancers
  • Liver cancer
  • Myeloma
  • Pancreatic cancer
  • PET
  • PET/CT
  • Sarcoma
  • Small cell lung cancer
  • Thyroid cancer

ASJC Scopus subject areas

  • Oncology

Cite this

Podoloff, D. A., Ball, D. W., Ben-Josef, E., Benson, A. B., Cohen, S. J., Coleman, R. E., ... Wong, R. J. (2009). NCCN Task Force: Clinical utility of PET in a variety of tumor types. JNCCN Journal of the National Comprehensive Cancer Network, 7(SUPPL. 2).

NCCN Task Force : Clinical utility of PET in a variety of tumor types. / Podoloff, Donald A.; Ball, Douglas W.; Ben-Josef, Edgar; Benson, Al B.; Cohen, Steven J.; Coleman, R. Edward; Delbeke, Dominique; Ho, Maria; Ilson, David H.; Kalemkerian, Gregory P.; Lee, Richard J.; Loeffler, Jay S.; Macapinlac, Homer A.; Morgan, Robert J.; Siegel, Barry Alan; Singhal, Seema; Tyler, Douglas; Wong, Richard J.

In: JNCCN Journal of the National Comprehensive Cancer Network, Vol. 7, No. SUPPL. 2, 2009.

Research output: Contribution to journalArticle

Podoloff, DA, Ball, DW, Ben-Josef, E, Benson, AB, Cohen, SJ, Coleman, RE, Delbeke, D, Ho, M, Ilson, DH, Kalemkerian, GP, Lee, RJ, Loeffler, JS, Macapinlac, HA, Morgan, RJ, Siegel, BA, Singhal, S, Tyler, D & Wong, RJ 2009, 'NCCN Task Force: Clinical utility of PET in a variety of tumor types', JNCCN Journal of the National Comprehensive Cancer Network, vol. 7, no. SUPPL. 2.
Podoloff DA, Ball DW, Ben-Josef E, Benson AB, Cohen SJ, Coleman RE et al. NCCN Task Force: Clinical utility of PET in a variety of tumor types. JNCCN Journal of the National Comprehensive Cancer Network. 2009;7(SUPPL. 2).
Podoloff, Donald A. ; Ball, Douglas W. ; Ben-Josef, Edgar ; Benson, Al B. ; Cohen, Steven J. ; Coleman, R. Edward ; Delbeke, Dominique ; Ho, Maria ; Ilson, David H. ; Kalemkerian, Gregory P. ; Lee, Richard J. ; Loeffler, Jay S. ; Macapinlac, Homer A. ; Morgan, Robert J. ; Siegel, Barry Alan ; Singhal, Seema ; Tyler, Douglas ; Wong, Richard J. / NCCN Task Force : Clinical utility of PET in a variety of tumor types. In: JNCCN Journal of the National Comprehensive Cancer Network. 2009 ; Vol. 7, No. SUPPL. 2.
@article{88320e01a56f4eaab4c08fe56bf689de,
title = "NCCN Task Force: Clinical utility of PET in a variety of tumor types",
abstract = "Use of PET is widespread and increasing in the United States, mainly for oncologic applications. In November 2006, the National Comprehensive Cancer Network (NCCN) gathered a panel of experts to review the literature and develop clinical recommendations for using PET scans in lymphoma and non-small cell lung, breast, and colorectal cancers. However, because its use is not restricted to these diseases, and evidence is accumulating for its application in other types of cancers, NCCN convened a second meeting in December 2008 to expand on the initial report. A multidisciplinary panel met to discuss the current data on PET application for various tumor types, including genitourinary, gynecologic, pancreatic, hepatobiliary, thyroid, brain, small cell lung, gastric, and esophageal cancers, and sarcoma and myeloma. This report summarizes the proceedings of this meeting, including discussions of the background of PET, the role of PET in oncology, principles of PET use, emerging applications, and possible future developments.",
keywords = "Biliary tract cancer, Brain cancer, Esophageal cancer, Gastric cancer, Genitourinary cancers, Gynecological cancers, Liver cancer, Myeloma, Pancreatic cancer, PET, PET/CT, Sarcoma, Small cell lung cancer, Thyroid cancer",
author = "Podoloff, {Donald A.} and Ball, {Douglas W.} and Edgar Ben-Josef and Benson, {Al B.} and Cohen, {Steven J.} and Coleman, {R. Edward} and Dominique Delbeke and Maria Ho and Ilson, {David H.} and Kalemkerian, {Gregory P.} and Lee, {Richard J.} and Loeffler, {Jay S.} and Macapinlac, {Homer A.} and Morgan, {Robert J.} and Siegel, {Barry Alan} and Seema Singhal and Douglas Tyler and Wong, {Richard J.}",
year = "2009",
language = "English (US)",
volume = "7",
journal = "Journal of the National Comprehensive Cancer Network : JNCCN",
issn = "1540-1405",
publisher = "Cold Spring Publishing LLC",
number = "SUPPL. 2",

}

TY - JOUR

T1 - NCCN Task Force

T2 - Clinical utility of PET in a variety of tumor types

AU - Podoloff, Donald A.

AU - Ball, Douglas W.

AU - Ben-Josef, Edgar

AU - Benson, Al B.

AU - Cohen, Steven J.

AU - Coleman, R. Edward

AU - Delbeke, Dominique

AU - Ho, Maria

AU - Ilson, David H.

AU - Kalemkerian, Gregory P.

AU - Lee, Richard J.

AU - Loeffler, Jay S.

AU - Macapinlac, Homer A.

AU - Morgan, Robert J.

AU - Siegel, Barry Alan

AU - Singhal, Seema

AU - Tyler, Douglas

AU - Wong, Richard J.

PY - 2009

Y1 - 2009

N2 - Use of PET is widespread and increasing in the United States, mainly for oncologic applications. In November 2006, the National Comprehensive Cancer Network (NCCN) gathered a panel of experts to review the literature and develop clinical recommendations for using PET scans in lymphoma and non-small cell lung, breast, and colorectal cancers. However, because its use is not restricted to these diseases, and evidence is accumulating for its application in other types of cancers, NCCN convened a second meeting in December 2008 to expand on the initial report. A multidisciplinary panel met to discuss the current data on PET application for various tumor types, including genitourinary, gynecologic, pancreatic, hepatobiliary, thyroid, brain, small cell lung, gastric, and esophageal cancers, and sarcoma and myeloma. This report summarizes the proceedings of this meeting, including discussions of the background of PET, the role of PET in oncology, principles of PET use, emerging applications, and possible future developments.

AB - Use of PET is widespread and increasing in the United States, mainly for oncologic applications. In November 2006, the National Comprehensive Cancer Network (NCCN) gathered a panel of experts to review the literature and develop clinical recommendations for using PET scans in lymphoma and non-small cell lung, breast, and colorectal cancers. However, because its use is not restricted to these diseases, and evidence is accumulating for its application in other types of cancers, NCCN convened a second meeting in December 2008 to expand on the initial report. A multidisciplinary panel met to discuss the current data on PET application for various tumor types, including genitourinary, gynecologic, pancreatic, hepatobiliary, thyroid, brain, small cell lung, gastric, and esophageal cancers, and sarcoma and myeloma. This report summarizes the proceedings of this meeting, including discussions of the background of PET, the role of PET in oncology, principles of PET use, emerging applications, and possible future developments.

KW - Biliary tract cancer

KW - Brain cancer

KW - Esophageal cancer

KW - Gastric cancer

KW - Genitourinary cancers

KW - Gynecological cancers

KW - Liver cancer

KW - Myeloma

KW - Pancreatic cancer

KW - PET

KW - PET/CT

KW - Sarcoma

KW - Small cell lung cancer

KW - Thyroid cancer

UR - http://www.scopus.com/inward/record.url?scp=67650436288&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=67650436288&partnerID=8YFLogxK

M3 - Article

VL - 7

JO - Journal of the National Comprehensive Cancer Network : JNCCN

JF - Journal of the National Comprehensive Cancer Network : JNCCN

SN - 1540-1405

IS - SUPPL. 2

ER -